조제 약국 시장 : 세계 산업 규모, 점유율, 동향, 기회, 예측 - 치료 분야별, 투여 경로별, 최종사용자별, 지역별, 경쟁별(2020-2030년)
Compounding Pharmacy Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Therapeutic Area, By Route of Administration, By End User By Region and Competition, 2020-2030F
상품코드:1881541
리서치사:TechSci Research
발행일:2025년 11월
페이지 정보:영문 183 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
한글목차
세계의 조제 약국 시장은 2024년에 129억 8,000만 달러로 평가되었으며, 2030년까지 CAGR 6.52%로 성장하여 189억 6,000만 달러에 달할 것으로 예측됩니다.
세계 조제 약국 시장은 약사가 개별 환자를 위한 맞춤형 의약품을 만들어 대량 생산된 의약품으로 충족되지 않는 고유한 치료 요구를 충족시키는 전문적 업무를 포함합니다. 이러한 맞춤화에는 특정 제형, 알레르겐 제거 또는 기호성 개선이 포함될 수 있습니다.
시장 개요
예측 기간
2026-2030년
시장 규모 : 2024년
129억 8,000만 달러
시장 규모 : 2030년
189억 6,000만 달러
CAGR : 2025-2030년
6.52%
가장 빠르게 성장하는 부문
통증 관리
최대 시장
북미
주요 시장 촉진요인
맞춤형 의약품에 대한 수요 증가는 세계 조제 약국 시장의 주요 촉진요인입니다. 환자들은 특정 알레르기, 고유한 용량, 또는 시판되지 않는 대체 투여 경로에 맞게 정밀하게 조정된 약물을 필요로 하는 경우가 많습니다.
주요 시장 과제
엄격하고 진화하는 규제 환경은 전 세계 조제 약국 시장에 큰 도전이 되고 있습니다. 관할권별 감독 체계의 차이와 품질 보증 및 안전과 관련된 복잡한 컴플라이언스 요건은 조제 약국에 상당한 업무적 복잡성과 재정적 부담을 주고 있습니다.
주요 시장 동향
첨단 조제 기술의 통합은 시장 성장의 주요 촉진요인으로, 조제 약국 내 자동화, 로봇 공학, 첨단 소프트웨어의 도입에 중점을 두고 있습니다. 이 통합은 정확도를 높이고, 인적 오류의 가능성을 줄이고, 전반적인 업무 효율성을 향상시키는 것을 목표로 하며, 엄격한 품질 기준을 준수하면서 복잡한 제제를 처리하고 생산량을 늘리는 데 매우 중요합니다.
목차
제1장 개요
제2장 조사 방법
제3장 주요 요약
제4장 고객의 소리
제5장 세계의 조제 약국 시장 전망
시장 규모 및 예측
금액별
시장 점유율과 예측
치료 분야별(통증 관리, 호르몬 대체요법, 피부질환, 영양 보충제, 기타 치료 분야)
투여 경로별(경구, 외용, 비경구, 기타 투여 경로)
최종사용자별(인간, 동물)
지역별
기업별(2024)
시장 맵
제6장 북미의 조제 약국 시장 전망
시장 규모 및 예측
시장 점유율과 예측
북미 : 국가별 분석
미국
캐나다
멕시코
제7장 유럽의 조제 약국 시장 전망
시장 규모 및 예측
시장 점유율과 예측
유럽 : 국가별 분석
독일
프랑스
영국
이탈리아
스페인
제8장 아시아태평양의 조제 약국 시장 전망
시장 규모 및 예측
시장 점유율과 예측
아시아태평양 : 국가별 분석
중국
인도
일본
한국
호주
제9장 중동 및 아프리카의 조제 약국 시장 전망
시장 규모 및 예측
시장 점유율과 예측
중동 및 아프리카 : 국가별 분석
사우디아라비아
아랍에미리트
남아프리카공화국
제10장 남미의 조제 약국 시장 전망
시장 규모 및 예측
시장 점유율과 예측
남미 : 국가별 분석
브라질
콜롬비아
아르헨티나
제11장 시장 역학
성장 촉진요인
과제
제12장 시장 동향과 발전
인수합병
제품 출시
최근 동향
제13장 세계의 조제 약국 시장 : SWOT 분석
제14장 Porter's Five Forces 분석
업계내 경쟁
신규 참여의 가능성
공급업체의 능력
고객의 능력
대체품의 위협
제15장 경쟁 구도
Wedgewood Pharmacy
B. Braun Medical Inc.
Fagron NV
Fresenius Kabi
Clinigen Group PLC
Dougherty's Pharmacy, Inc.
Lorraine's Pharmacy
Rx3 Compounding Pharmacy
Institutional Pharmacy Solutions
Mcguff compounding pharmacy services
제16장 전략적 제안
제17장 조사 회사 소개 및 면책사항
KSM
영문 목차
영문목차
The Global Compounding Pharmacy Market, valued at USD 12.98 Billion in 2024, is projected to experience a CAGR of 6.52% to reach USD 18.96 Billion by 2030. The global compounding pharmacy market encompasses the specialized practice of pharmacists creating tailored medications for individual patients, addressing unique therapeutic requirements that are not fulfilled by mass-produced pharmaceuticals. This customization may involve specific dosage forms, allergen removal, or enhanced palatability.
Market Overview
Forecast Period
2026-2030
Market Size 2024
USD 12.98 Billion
Market Size 2030
USD 18.96 Billion
CAGR 2025-2030
6.52%
Fastest Growing Segment
Pain Management
Largest Market
North America
Key Market Drivers
The increasing demand for personalized medication is a primary catalyst for the Global Compounding Pharmacy Market. Patients frequently require pharmaceutical formulations precisely adjusted for specific allergies, unique dosage strengths, or alternative administration routes not commercially available. This customization is crucial for optimizing therapeutic outcomes and minimizing adverse reactions, driving demand for tailored solutions. According to the Alliance for Pharmacy Compounding, in their "2023-2024 Compounding Pharmacy Snapshot" published in July 2024, in the median hybrid pharmacy, 3% of all prescriptions were for compounded medications, demonstrating significant reliance on individualized preparations.
Key Market Challenges
The stringent and evolving regulatory environment presents a significant challenge to the global compounding pharmacy market. Varying jurisdictional oversight and complex compliance requirements for quality assurance and safety impose considerable operational complexities and financial burdens on compounding pharmacies. These escalating demands directly impede market expansion by increasing operating costs and diverting resources from potential growth initiatives. For instance, according to the Alliance for Pharmacy Compounding, in Fall 2023, 15% of all surveyed compounding pharmacies ceased hazardous drug compounding due to compliance costs associated with new USP Chapter <800> standards.
Key Market Trends
Advanced Compounding Technology Integration is a key driver for market growth, emphasizing the adoption of automation, robotics, and sophisticated software within compounding pharmacies. This integration aims to enhance precision, reduce the potential for human error, and improve overall operational efficiency, which is crucial for handling complex formulations and increasing production volumes while adhering to stringent quality standards. This trend supports pharmacies in meeting the evolving demands for customized medications. According to the Alliance for Pharmacy Compounding's demographic survey in Fall 2023, 529 unique 503A compounding pharmacies or 503B outsourcing facilities were represented, underscoring the significant number of entities potentially benefiting from these technological advancements.
Key Market Players
Wedgewood Pharmacy
B. Braun Medical Inc.
Fagron NV
Fresenius Kabi
Clinigen Group PLC
Dougherty's Pharmacy, Inc.
Lorraine's Pharmacy
Rx3 Compounding Pharmacy
Institutional Pharmacy Solutions
Mcguff compounding pharmacy services
Report Scope:
In this report, the Global Compounding Pharmacy Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Compounding Pharmacy Market, By Therapeutic Area:
Pain Management
Hormone Replacement
Dermal Disorders
Nutritional Supplements
Other Therapeutic Areas
Compounding Pharmacy Market, By Route of Administration:
Oral
Topical
Parenteral
Other Route of Administrations
Compounding Pharmacy Market, By End User:
Humans
Veterinary
Compounding Pharmacy Market, By Region:
North America
United States
Canada
Mexico
Europe
France
United Kingdom
Italy
Germany
Spain
Asia Pacific
China
India
Japan
Australia
South Korea
South America
Brazil
Argentina
Colombia
Middle East & Africa
South Africa
Saudi Arabia
UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies presents in the Global Compounding Pharmacy Market.
Available Customizations:
Global Compounding Pharmacy Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
Detailed analysis and profiling of additional market players (up to five).
Table of Contents
1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global Compounding Pharmacy Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Therapeutic Area (Pain Management, Hormone Replacement, Dermal Disorders, Nutritional Supplements, Other Therapeutic Areas)
5.2.2. By Route of Administration (Oral, Topical, Parenteral, Other Route of Administrations)
5.2.3. By End User (Humans, Veterinary)
5.2.4. By Region
5.2.5. By Company (2024)
5.3. Market Map
6. North America Compounding Pharmacy Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Therapeutic Area
6.2.2. By Route of Administration
6.2.3. By End User
6.2.4. By Country
6.3. North America: Country Analysis
6.3.1. United States Compounding Pharmacy Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Therapeutic Area
6.3.1.2.2. By Route of Administration
6.3.1.2.3. By End User
6.3.2. Canada Compounding Pharmacy Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Therapeutic Area
6.3.2.2.2. By Route of Administration
6.3.2.2.3. By End User
6.3.3. Mexico Compounding Pharmacy Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Therapeutic Area
6.3.3.2.2. By Route of Administration
6.3.3.2.3. By End User
7. Europe Compounding Pharmacy Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Therapeutic Area
7.2.2. By Route of Administration
7.2.3. By End User
7.2.4. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Compounding Pharmacy Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Therapeutic Area
7.3.1.2.2. By Route of Administration
7.3.1.2.3. By End User
7.3.2. France Compounding Pharmacy Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Therapeutic Area
7.3.2.2.2. By Route of Administration
7.3.2.2.3. By End User
7.3.3. United Kingdom Compounding Pharmacy Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Therapeutic Area
7.3.3.2.2. By Route of Administration
7.3.3.2.3. By End User
7.3.4. Italy Compounding Pharmacy Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Therapeutic Area
7.3.4.2.2. By Route of Administration
7.3.4.2.3. By End User
7.3.5. Spain Compounding Pharmacy Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Therapeutic Area
7.3.5.2.2. By Route of Administration
7.3.5.2.3. By End User
8. Asia Pacific Compounding Pharmacy Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Therapeutic Area
8.2.2. By Route of Administration
8.2.3. By End User
8.2.4. By Country
8.3. Asia Pacific: Country Analysis
8.3.1. China Compounding Pharmacy Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Therapeutic Area
8.3.1.2.2. By Route of Administration
8.3.1.2.3. By End User
8.3.2. India Compounding Pharmacy Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Therapeutic Area
8.3.2.2.2. By Route of Administration
8.3.2.2.3. By End User
8.3.3. Japan Compounding Pharmacy Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Therapeutic Area
8.3.3.2.2. By Route of Administration
8.3.3.2.3. By End User
8.3.4. South Korea Compounding Pharmacy Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Therapeutic Area
8.3.4.2.2. By Route of Administration
8.3.4.2.3. By End User
8.3.5. Australia Compounding Pharmacy Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Therapeutic Area
8.3.5.2.2. By Route of Administration
8.3.5.2.3. By End User
9. Middle East & Africa Compounding Pharmacy Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Therapeutic Area
9.2.2. By Route of Administration
9.2.3. By End User
9.2.4. By Country
9.3. Middle East & Africa: Country Analysis
9.3.1. Saudi Arabia Compounding Pharmacy Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Therapeutic Area
9.3.1.2.2. By Route of Administration
9.3.1.2.3. By End User
9.3.2. UAE Compounding Pharmacy Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Therapeutic Area
9.3.2.2.2. By Route of Administration
9.3.2.2.3. By End User
9.3.3. South Africa Compounding Pharmacy Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Therapeutic Area
9.3.3.2.2. By Route of Administration
9.3.3.2.3. By End User
10. South America Compounding Pharmacy Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Therapeutic Area
10.2.2. By Route of Administration
10.2.3. By End User
10.2.4. By Country
10.3. South America: Country Analysis
10.3.1. Brazil Compounding Pharmacy Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Therapeutic Area
10.3.1.2.2. By Route of Administration
10.3.1.2.3. By End User
10.3.2. Colombia Compounding Pharmacy Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Therapeutic Area
10.3.2.2.2. By Route of Administration
10.3.2.2.3. By End User
10.3.3. Argentina Compounding Pharmacy Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Therapeutic Area
10.3.3.2.2. By Route of Administration
10.3.3.2.3. By End User
11. Market Dynamics
11.1. Drivers
11.2. Challenges
12. Market Trends & Developments
12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments
13. Global Compounding Pharmacy Market: SWOT Analysis
